Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.
about
Epidemiology and clinical course of Crohn's disease: results from observational studiesAdalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trialInfluence of treatment on morphological features of mucosal inflammationRecent advances of endoscopy in inflammatory bowel diseases.Review article: diet and inflammatory bowel disease--epidemiology and treatment.Limitations in assessment of mucosal healing in inflammatory bowel diseaseRate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.Successful treatment of postoperative fistula with infliximab in a patient with Crohn's disease.Comparing outcomes between side-to-side anastomosis and other anastomotic configurations after intestinal resection for patients with Crohn's disease: a meta-analysis.Pathology of inflammatory bowel diseases (IBD): variability with time and treatment.Medical therapy in Crohn's disease.Factors affecting recurrence after surgery for Crohn's disease.Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.How to read a clinical trial paper: a lesson in basic trial statistics.Infliximab use in Crohn's disease.Synergy between immunosuppressive therapy and enteral nutrition in the management of childhood Crohn's disease.Preoperative Nutritional Therapy Reduces the Risk of Anastomotic Leakage in Patients with Crohn's Disease Requiring ResectionsMucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?Inflammatory bowel disease and African Americans: a systematic review.Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease.What is the optimal therapy for Crohn's disease: step-up or top-down?Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.Immunomodulators for all patients with inflammatory bowel disease?Mucosal healing in Crohn's disease: a systematic review.The role of mucosal healing in the treatment of patients with inflammatory bowel diseaseFecal biomarkers in the diagnosis and monitoring of Crohn's disease.IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease.Assessment of disease severity and activity in inflammatory bowel disease.Does Anastomosis Configuration Influence Long-term Outcomes in Patients With Crohn Disease?Monocyte-derived dendritic cells from Crohn's disease patients exhibit decreased ability to activate T helper type 17 responses in memory cells.Mucosal healing in pediatric Crohn's disease: the goal of medical treatment.
P2860
Q22241217-C6970506-79BE-45E0-A203-443E0B2096F7Q26829488-5737909E-3F3F-47B1-AA5D-8F94E2AECBD5Q28192791-AD2448DA-64A6-42EC-B75A-9795E5579623Q30481461-5A59D347-0377-4E16-AF24-0995AFFB3918Q33445163-007AB77F-B614-48B9-ABAB-121E20E103A5Q33564957-580719F0-D98B-4FAD-B66E-444F9A61D92FQ33763285-49EADF52-63FD-4B3A-9CB9-DBBEE69B722FQ34367007-E98BDBE7-C9BA-4B0D-A561-4FB0125EFABBQ34375104-AF2BC4D2-BE7C-4A1E-92BA-86819CA14B72Q34378062-4B0A39B7-38C0-4AD6-BEF4-8E08DEE2731DQ34378561-9CAC746E-6141-4E1F-8FAA-C867D4BE10FEQ34564888-E0534374-44CD-422F-A323-AB4690B78312Q35147234-7E41E303-CF75-4BF2-A4EB-6BF2BDC82150Q35272521-D5426DA3-C61A-402C-A5E5-5AA0133F75C9Q35851097-B0027856-CEEE-4976-96AF-AADD32E370B2Q35933419-D3A19EF1-D0D3-4D4A-A6D2-CBCC35973816Q36049663-27CBF6E0-64ED-4807-8976-097B5723AC07Q36150474-F2BAC98B-ADF0-41FE-85AC-A97E9F0517D4Q36175772-64A75199-CE19-4CF2-88BE-D92A90CBC14DQ36447024-76D0833E-1DD6-4E2F-A019-ED2EEAB74796Q36763425-F14F68C6-3478-4166-B17C-B35914534A7FQ37081543-1F293B0D-6425-4239-8B7F-85B5303B2348Q37276962-925B12AC-C2C5-4598-A6FD-5C86D8B1AD7FQ37720746-FDFB7CAD-D05C-4A74-94F5-75480FB55D1EQ37806150-F3BFD5E5-BB29-4317-BA0E-DC2CB23FECA7Q37823320-EE7D93C1-634F-4CCD-B5AF-13F12EFA6177Q38005972-BC6FE966-D644-433B-8DC0-F265ACF3694DQ38176299-33D9BE42-A5D0-4554-B1D8-BB1169955F50Q38219444-E7C9B8FB-9E2B-41D9-AD0A-2CAD5AC33CBCQ38583688-A4A9621B-7205-4C18-A065-78B1CA1F69DDQ38671272-558DD47E-4232-4591-BD50-D0B2453FAF31Q40874249-E17F6469-ABB8-4D99-B401-001C0933F784Q47163441-8D5BBEBE-122A-48C6-826E-B6C39162BCE2Q50857085-6B3B32AC-E269-4542-B992-E61C352B7B3FQ53883128-8FF03798-C3E2-4BCC-9FD5-55CC636BAC2F
P2860
Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Glucocorticoid treatment in il ...... copically viewed inflammation.
@ast
Glucocorticoid treatment in il ...... copically viewed inflammation.
@en
Glucocorticoid treatment in il ...... copically viewed inflammation.
@nl
type
label
Glucocorticoid treatment in il ...... copically viewed inflammation.
@ast
Glucocorticoid treatment in il ...... copically viewed inflammation.
@en
Glucocorticoid treatment in il ...... copically viewed inflammation.
@nl
prefLabel
Glucocorticoid treatment in il ...... copically viewed inflammation.
@ast
Glucocorticoid treatment in il ...... copically viewed inflammation.
@en
Glucocorticoid treatment in il ...... copically viewed inflammation.
@nl
P2093
P2860
P356
P1433
P1476
Glucocorticoid treatment in il ...... copically viewed inflammation.
@en
P2093
P2860
P304
P356
10.1136/GUT.31.3.325
P407
P577
1990-03-01T00:00:00Z